Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Gross Profit of $0.00 for fiscal year 2023.
ACRO BIOMEDICAL CO., LTD. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $140.5K | -45.9% |
| 2021 | $259.5K | +62.8% |
| 2020 | $159.4K | +1217.8% |
| 2019 | $12.1K | -91.1% |
| 2019 | $135.4K | -83.8% |
| 2018 | $833.4K | +1534.1% |
| 2017 | $51.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
| March 31, 2023 | $0.00 | -100.0% | — |
| September 30, 2022 | $0.00 | — | — |
| June 30, 2022 | $0.00 | -100.0% | -100.0% |
| March 31, 2022 | $76.5K | +159.3% | — |
| September 30, 2021 | $0.00 | — | -100.0% |
| June 30, 2021 | $80.0K | — | +171.2% |
- ACRO BIOMEDICAL CO., LTD. showed a decrease of -100.0% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2023 period, ACRO BIOMEDICAL CO., LTD.’s gross profit has declined by 100.0% (from $51.0 thousand to $0.00).
- The most recent figure is from ACRO BIOMEDICAL CO., LTD.’s fiscal year 2023 report (Form 10-K), filed with the SEC on July 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: